Just prior to the close of their proposed merger, Cyberonics, Inc. CYBX and Sorin S.p.A. jointly announced the two remaining designees to the Board of Directors of LivaNova – the combined company to ...

We have reiterated our Neutral recommendation on Cyberonics Inc. (CYBX) with a target price of $46.00, following our assessment of its fourth quarter and fiscal 2012 results. Cyberonics reported ...

Look here for a clue. There's no foolproof way to know the future for Cyberonics (Nasdaq: CYBX) or any other company. However, certain clues may help you see potential stumbles before they happen -- ...

Cyberonics has made a minority investment in Cerbomed GmbH. The inital investment is €2 million (US$2.6 million) but that can total € 5.5 million, subject to the achievement of certain clinical ...

Cyberonics, which makes a device that treats epilepsy, disclosed Monday it received a warning letter last month from the FDA citing problems inspectors found at its Houston manufacturing plant. The ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: The ...

NEW YORK (AP) -- Shares of Cyberonics Inc. rose Monday on news that a former employee had dropped his lawsuit against the neurological device maker. THE SPARK: Cyberonics said that Andrew Hagerty ...

HOUSTON, Feb. 25, 2015 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced it received CE (Conformite Europeenne) Mark of the VITARIA™ System for delivering autonomic regulation therapy ...

Cyberonics, Inc. CYBX shares gained more than 20 percent after the company said it will merge with Italian-based Sorin SpA in a stock-swap valuing the two companies at $2.7 billion. Cyberonics changed ...

So much for efficient markets. Even though Cyberonics' (NASDAQ:CYBX) management had been telling investors for some time that an eventual launch of a therapy for treatment-resistant depression would ...

The tumultuous tenure of Robert P. Cummins as chairman, president and chief executive of the medical device maker Cyberonics has ended, the company disclosed yesterday. Mr. Cummins, 52, who is known ...

Cyberonics, the troubled maker of implantable stimulators, said yesterday that it had recruited a senior Boston Scientific marketing executive to become its chief executive and that it would aim to ...